T cell receptor engagement by peptide–MHC ligands induces a conformational change in the CD3 complex of thymocytes

D Gil, AG Schrum, B Alarcón, E Palmer - The Journal of experimental …, 2005 - rupress.org
D Gil, AG Schrum, B Alarcón, E Palmer
The Journal of experimental medicine, 2005rupress.org
The T cell receptor (TCR) can recognize a variety of cognate peptide/major
histocompatibility complex (pMHC) ligands and translate their affinity into distinct cellular
responses. To achieve this, the nonsignaling αβ heterodimer communicates ligand
recognition to the CD3 signaling subunits by an unknown mechanism. In thymocytes, we
found that both positive-and negative-selecting pMHC ligands expose a cryptic epitope in
the CD3 complex upon TCR engagement. This conformational change is induced in vivo …
The T cell receptor (TCR) can recognize a variety of cognate peptide/major histocompatibility complex (pMHC) ligands and translate their affinity into distinct cellular responses. To achieve this, the nonsignaling αβ heterodimer communicates ligand recognition to the CD3 signaling subunits by an unknown mechanism. In thymocytes, we found that both positive- and negative-selecting pMHC ligands expose a cryptic epitope in the CD3 complex upon TCR engagement. This conformational change is induced in vivo and requires the expression of cognate MHC. We conclude that TCR engagement with a cognate pMHC ligand induces a conformational change in the CD3 complex of thymocytes and propose that this marks an initial event during thymic selection that signals the recognition of self-antigen.
rupress.org